Portal de investigação
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Ropio, J
- Prochazkova Carlotti, M
- Batista, R
- Pestana, A
- Chebly, A
- Ferrer, J
- Idrissi, Y
- Cappellen, D
- Duraes, C
- Boaventura, P
- Vinagre, J
- Azzi Martin, L
- Poglio, S
- Cabeçadas, J
- Campos, MA
- Beylot Barry, M
- Sobrinho Simoes, M
- Merlio, JP
- Chevret, E
Unidades de investigação
Abstract
As a major cancer hallmark, there is a sustained interest in understanding the telomerase contribution to carcinogenesis in order to therapeutically target this enzyme. This is particularly relevant in primary cutaneous T-cell lymphomas (CTCL), a malignancy showing telomerase dysregulation with few investigative data available. In CTCL, we examined the mechanisms involved in telomerase transcriptional activation and activity regulation. We analyzed 94 CTCL patients from a Franco-Portuguese cohort, as well as 8 cell lines, in comparison to 101 healthy controls. Our results showed that not only polymorphisms (SNPs) located at the promoter of human telomerase reverse transcriptase (hTERT) gene (rs2735940 and rs2853672) but also an SNP located within the coding region (rs2853676) could influence CTCL occurrence. Furthermore, our results sustained that the post-transcriptional regulation of hTERT contributes to CTCL lymphomagenesis. Indeed, CTCL cells present a different pattern of hTERT spliced transcripts distribution from the controls, mostly marked by an increase in the hTERT beta+ variants proportion. This increase seems to be associated with CTCL development and progression. Through hTERT splicing transcriptome modulation with shRNAs, we observed that the decrease in the alpha-beta+ transcript induced a decrease in the cell proliferation and tumorigenic capacities of T-MF cells in vitro. Taken together, our data highlight the major role of post-transcriptional mechanisms regulating telomerase non canonical functions in CTCL and suggest a new potential role for the alpha-beta+ hTERT transcript variant.
Dados da publicação
- ISSN/ISSNe:
- 2073-4425, 2073-4425
- Tipo:
- Article
- Páginas:
- 439-
- Link para outro recurso:
- www.scopus.com
Genes Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- CTCL; telomerase; hTERT; promoter mutations; SNP; splicing variants
Campos de estudo
Financiamento
Proyectos asociados
Selenium Clinical Supplementation In Autoimmune Thyroid Disease: A Portuguese Survey
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Squamous cell carcinogenesis of the skin: Molecular characterization of prognostic therapeutic biomakers
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Clinicopathological features and molecular biomarkers? role predicting papillary thyroid cancer patients? outcome: How to personalize and guide surgical treatment
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Fatores do microambiente tumoral no cancro do ovário.
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Citar a publicação
Ropio J,Prochazkova M,Batista R,Pestana A,Chebly A,Ferrer J,Idrissi Y,Cappellen D,Duraes C,Boaventura P,Vinagre J,Azzi L,Poglio S,Cabeçadas J,Campos MA,Beylot M,Sobrinho M,Merlio JP,Soares Dias Ferreira A,Chevret E. Spotlight on <i>hTERT</i> Complex Regulation in Cutaneous T-Cell Lymphomas. Genes. 2023. 14. (2):p. 439-439. IF:3,500. (2).
